Celularity Net Income Per Share from 2010 to 2024

CELU Stock  USD 2.01  0.84  29.47%   
Celularity Net Loss yearly trend continues to be comparatively stable with very little volatility. Net Loss will likely drop to -11.57 in 2024. From the period from 2010 to 2024, Celularity Net Loss quarterly data regression had mean square error of  36.34 and mean deviation of  5.33. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
(11.02)
Current Value
(11.57)
Quarterly Volatility
6.94063562
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Celularity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celularity's main balance sheet or income statement drivers, such as Interest Expense of 2.8 M, Ebit of 17.2 M or Net Income Applicable To Common Shares of 17.1 M, as well as many indicators such as Price To Sales Ratio of 1.84, Dividend Yield of 0.0 or PTB Ratio of 1.13. Celularity financial statements analysis is a perfect complement when working with Celularity Valuation or Volatility modules.
  
Check out the analysis of Celularity Correlation against competitors.
For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

Latest Celularity's Net Income Per Share Growth Pattern

Below is the plot of the Net Income Per Share of Celularity over the last few years. It is Celularity's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Celularity's overall financial position and show how it may be relating to other accounts over time.
Net Income Per Share10 Years Trend
Slightly volatile
   Net Income Per Share   
       Timeline  

Celularity Net Income Per Share Regression Statistics

Arithmetic Mean(3.33)
Coefficient Of Variation(208.48)
Mean Deviation5.33
Median(0.000031)
Standard Deviation6.94
Sample Variance48.17
Range25.1297
R-Value(0.55)
Mean Square Error36.34
R-Squared0.30
Significance0.03
Slope(0.85)
Total Sum of Squares674.41

Celularity Net Income Per Share History

2024 -11.57
2023 -11.02
2022 0.9
2021 -8.04
2020 -22.67
2019 2.46

About Celularity Financial Statements

Celularity shareholders use historical fundamental indicators, such as Net Income Per Share, to determine how well the company is positioned to perform in the future. Although Celularity investors may analyze each financial statement separately, they are all interrelated. The changes in Celularity's assets and liabilities, for example, are also reflected in the revenues and expenses on on Celularity's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss(11.02)(11.57)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.